TP53 mutations are found in 5–10% of MDS patients affected and are associated with an excess of blasts and complex karyotype (including abnormalities of chromosome 17 or deletions of chromosome 5 and 7) [14,15,16]. The gene discussed is TP53; the disease is myelodysplastic syndrome.